FI942181A - Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet - Google Patents
Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet Download PDFInfo
- Publication number
- FI942181A FI942181A FI942181A FI942181A FI942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- pharmaceutical preparations
- preparations containing
- lupane derivatives
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9113907A FR2683531B1 (fr) | 1991-11-13 | 1991-11-13 | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
PCT/FR1992/001046 WO1993010142A1 (fr) | 1991-11-13 | 1992-11-12 | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
FI942181A0 FI942181A0 (fi) | 1994-05-11 |
FI942181A true FI942181A (fi) | 1994-05-11 |
Family
ID=9418832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI942181A FI942181A (fi) | 1991-11-13 | 1994-05-11 | Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet |
Country Status (11)
Country | Link |
---|---|
US (1) | US5468888A (fi) |
EP (2) | EP0542622A1 (fi) |
CA (1) | CA2121692A1 (fi) |
FI (1) | FI942181A (fi) |
FR (1) | FR2683531B1 (fi) |
HU (1) | HUT66959A (fi) |
IL (1) | IL103731A0 (fi) |
MX (1) | MX9206503A (fi) |
TW (1) | TW224103B (fi) |
WO (1) | WO1993010142A1 (fi) |
YU (1) | YU97492A (fi) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869535A (en) * | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
US5658947A (en) * | 1995-03-21 | 1997-08-19 | Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma using betalinic acid |
US5962527A (en) * | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
EP0988311B9 (en) * | 1997-06-04 | 2004-12-15 | Cornell Research Foundation, Inc. | Betulinol derivatives |
US6403816B1 (en) * | 1997-09-30 | 2002-06-11 | Dabur Research Foundation | Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
JP2002505337A (ja) * | 1998-03-02 | 2002-02-19 | ザ ユニバーシティ オブ ノース キャロライナ アット チャペル ヒル | アシル化ベツリンおよびジヒドロベツリンの誘導体、その調製物、およびそれらの使用 |
US6369101B1 (en) | 1999-02-26 | 2002-04-09 | Regents Of The University Of Minnesota | Therapeutic method to treat herpes virus infection |
US6392070B1 (en) * | 1999-08-10 | 2002-05-21 | Regents Of The University Of Minnesota | Birch bark processing and the isolation of natural products from birch bark |
BR9917495A (pt) * | 1999-09-09 | 2002-06-11 | Dabur Res Foundation | Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores |
WO2002016395A1 (en) * | 2000-08-18 | 2002-02-28 | The Board Of Trustees Of The University Of Illinois | Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
EP2567625A1 (en) * | 2001-05-11 | 2013-03-13 | University Of Ottawa | Preparation containing betulinic acid, obtained from a plant of the family Marcgraviaceae |
GB0128071D0 (en) * | 2001-11-22 | 2002-01-16 | Cyclacel Ltd | Medicament |
US20040265320A1 (en) * | 2003-01-29 | 2004-12-30 | Karl Salzwedel | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
US7537765B2 (en) * | 2003-01-29 | 2009-05-26 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
US7026305B2 (en) * | 2003-04-14 | 2006-04-11 | Meharry Medical College | Anti-HIV agents with dual sites of action |
US7326717B2 (en) * | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
CA2560266A1 (en) * | 2004-03-17 | 2005-09-29 | Panacos Pharmaceuticals, Inc. | Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
WO2005112929A2 (en) * | 2004-05-20 | 2005-12-01 | Cornell Research Foundation, Inc. | Anti-hiv-1 activity of betulinol derivatives |
US7282521B2 (en) * | 2004-05-24 | 2007-10-16 | University Of North Carolina At Chapel Hill | Anti-retroviral moronic acid derivatives |
US20060154904A1 (en) * | 2004-09-10 | 2006-07-13 | Cornell Research Foundation, Inc. | Betulinol derivatives as anti-HIV agents |
TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
US20060193804A1 (en) * | 2005-02-24 | 2006-08-31 | L'oreal | Haircare use of cyclic amine derivatives |
BRPI0610668A2 (pt) | 2005-04-12 | 2010-07-13 | Panacos Pharmaceuticals Inc | polimorfas de di-n-metil-d-glucamina do ácido 3-o-(3',3'-dimetilsuccinil) betulìnico |
WO2007002411A1 (en) * | 2005-06-22 | 2007-01-04 | Myriad Genetics, Inc. | Antiviral compounds |
JP2009527563A (ja) * | 2006-02-21 | 2009-07-30 | アキリオン ファーマシューティカルズ,インコーポレーテッド | ウイルス感染症を治療するのに有用な置換タラキサスタン |
US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
US20090105203A1 (en) * | 2006-10-16 | 2009-04-23 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
RU2317996C1 (ru) * | 2006-10-30 | 2008-02-27 | Институт нефтехимии и катализа РАН | N'-{n-[3-оксо-лупан-28-оил]-9-аминононаноил}-3-амино-3-фенил-пропионовая кислота и ее соли как противовирусные и иммуностимулирующие агенты |
US20090062243A1 (en) * | 2007-08-03 | 2009-03-05 | Advanced Life Sciences, Inc. | Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof |
FR2920309B1 (fr) | 2007-08-28 | 2010-05-28 | Galderma Res & Dev | Utilisation de travoprost pour traiter la chute des cheveux |
WO2009090063A1 (en) * | 2008-01-16 | 2009-07-23 | Jado Technologies Gmbh | Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases |
FR2929118B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
FR2929117B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
KR100941595B1 (ko) * | 2008-06-05 | 2010-02-11 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 트리테르페노이드계 화합물 |
FR2949052B1 (fr) | 2009-08-13 | 2015-03-27 | Oreal | Procede de traitement cosmetique du cuir chevelu. |
CN102558280B (zh) * | 2011-11-18 | 2014-09-17 | 温州大学 | 一种30-卤代桦木酸的生产方法 |
PL2838533T3 (pl) | 2012-04-16 | 2018-03-30 | Case Western Reserve University | Kompozycje i sposoby modulowania aktywności 15-PGDH |
EP2953960A1 (en) * | 2013-02-06 | 2015-12-16 | Bristol-Myers Squibb Company | C-19 modified triterpenoids with hiv maturation inhibitory activity |
JP6517197B2 (ja) | 2013-10-15 | 2019-05-22 | ケース ウエスタン リザーブ ユニバーシティ | 短鎖デヒドロゲナーゼ活性を調節する組成物および方法 |
CN104045680B (zh) | 2014-06-20 | 2016-09-14 | 东北林业大学 | 桦木醇的乙酰氨基酸酰类衍生物及其制备方法 |
AU2015357489A1 (en) | 2014-12-05 | 2017-07-06 | Case Western Reserve University | Compositions and methods of modulating S-nitrosylation |
PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
US10688037B1 (en) | 2015-12-31 | 2020-06-23 | Nutraceutical Wellness Inc. | Compositions and method for hair regrowth |
US11690847B2 (en) | 2016-11-30 | 2023-07-04 | Case Western Reserve University | Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof |
JP2020514323A (ja) | 2017-02-06 | 2020-05-21 | ケース ウエスタン リザーブ ユニバーシティ | 短鎖デヒドロゲナーゼ活性を調節する組成物と方法 |
PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
EP3883577A4 (en) | 2018-11-21 | 2022-06-15 | Case Western Reserve University | COMPOSITIONS AND METHODS FOR MODULATION OF SHORT CHAIN DEHYDROGENASE ACTIVITY |
AU2021275122A1 (en) | 2020-05-20 | 2022-12-15 | Board Of Regents Of The University Of Texas System | Compositions and methods of modulating short-chain dehydrogenase activity |
-
1991
- 1991-11-13 FR FR9113907A patent/FR2683531B1/fr not_active Expired - Fee Related
-
1992
- 1992-11-10 TW TW081108971A patent/TW224103B/zh active
- 1992-11-12 EP EP92403046A patent/EP0542622A1/fr not_active Withdrawn
- 1992-11-12 WO PCT/FR1992/001046 patent/WO1993010142A1/fr not_active Application Discontinuation
- 1992-11-12 IL IL103731A patent/IL103731A0/xx unknown
- 1992-11-12 MX MX9206503A patent/MX9206503A/es unknown
- 1992-11-12 EP EP93900240A patent/EP0613483A1/fr not_active Withdrawn
- 1992-11-12 YU YU97492A patent/YU97492A/sh unknown
- 1992-11-12 CA CA002121692A patent/CA2121692A1/fr not_active Abandoned
- 1992-11-12 HU HU9401353A patent/HUT66959A/hu unknown
-
1994
- 1994-05-11 FI FI942181A patent/FI942181A/fi unknown
- 1994-05-12 US US08/243,341 patent/US5468888A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU9401353D0 (en) | 1994-08-29 |
YU97492A (sh) | 1995-12-04 |
FR2683531B1 (fr) | 1993-12-31 |
HUT66959A (en) | 1995-01-30 |
IL103731A0 (en) | 1993-04-04 |
FI942181A0 (fi) | 1994-05-11 |
FR2683531A1 (fr) | 1993-05-14 |
TW224103B (fi) | 1994-05-21 |
US5468888A (en) | 1995-11-21 |
WO1993010142A1 (fr) | 1993-05-27 |
MX9206503A (es) | 1993-05-01 |
EP0542622A1 (fr) | 1993-05-19 |
CA2121692A1 (fr) | 1993-05-27 |
EP0613483A1 (fr) | 1994-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI942181A (fi) | Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
EE9400455A (et) | Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine | |
EE03110B1 (et) | Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid | |
IT8847556A0 (it) | Derivati peptidici, loro preparazione e loro impiego come medicamenti | |
FI942913A (fi) | Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
NO922005D0 (no) | Farmasoeytiske preparater | |
FI943571A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
DE3480599D1 (de) | 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. | |
IT8947823A0 (it) | Derivati peptidici, loro preparazione e loro impiego come medicamenti | |
DE3483713D1 (de) | Hydroxypyridon-derivate und sie enthaltende pharmazeutische zubereitungen. | |
EE03111B1 (et) | Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid | |
DE69014351D1 (de) | Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
DK489189D0 (da) | Farmaceutisk praeparat | |
DE68917499D1 (de) | Catechol-Derivate und sie enthaltende pharmazeutische Präparate. | |
IT1203743B (it) | Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti | |
DE3682960D1 (de) | Pharmazeutische praeparate. | |
FI961938A0 (fi) | Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
DK496889D0 (da) | Peptidholdigt farmaceutisk praeparat | |
DK603988D0 (da) | Farmaceutisk praeparat | |
EE9400148A (et) | Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid | |
DK635988A (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
DK336489A (da) | Farmaceutisk praeparat | |
BR9106372A (pt) | Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico | |
KR900700471A (ko) | 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법 | |
NO924563D0 (no) | Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser |